On the one hand, in vitro generation of MDSCs with the help of cytokines – like GM-CSF and IL-6 – or pharmacological compounds – such as PGE2 –, followed by adoptive transfer is an effective and increasingly established treatment in murine models of chronic inflammatory diseases, autoimmune diseases, and allograft transplantation. The gene discussed is CSF2; the disease is autoimmune disease.